Thyrocare Technologies Limited
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
What Thyrocare files
- Others82
- Investor Meet26
- Important23
- Updates18
- Insider Trade13
- Board Meeting10
The amalgamation of Docon Technologies with API Holdings has been sanctioned. API Holdings will now directly hold the 51.02% (8.12 Cr shares) promoter stake in the Company, simplifying the group structure without changing overall promoter shareholding.
Thyrocare's promoter, Docon Technologies, secured the release of pledge over 7.95 crore shares. This follows API Holdings' full repayment of INR 1,050 Cr in Non-Convertible Debentures. The promoter's entire Thyrocare shareholding is now pledge-free, enhancing financial stability.
Thyrocare's promoter, Docon Technologies, sold 1.58 Cr shares, reducing its stake from 60.92% to 51.02%. This represents 9.90% of total equity. Docon remains a promoter.
Thyrocare promoter, Docon Technologies, released pledge on 1.75 crore shares, reducing encumbered holding from 60.92% to 49.93%. This move strengthens the promoter's financial position; group's outstanding Non-Convertible Debentures are 1,050 Cr.
Thyrocare Technologies reported robust Q1 financial results. Consolidated revenue grew to 240.02 Cr, with profit reaching 51.33 Cr. The Diagnostic Testing Services segment demonstrated strong performance, and Imaging Services notably turned profitable, signaling operational improvements.